MIR4490

Across TCGA pan-cancer cohorts, MIR4490 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR4490 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4490 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4490 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

KIRC, ESCA, and STAD are the cancer types where MIR4490 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.127	0.806	<.001	144	view →
ESCA	OS	Tertile	II,III,IV	0.515	0.728	.015	18	view →
STAD	OS	Tertile	IV	0.805	0.272	.033	12	view →
LUAD	OS	Tertile	All	0.176	0.670	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR4490–KIRC (OS)

Open the KIRC breakdown →